Drug recall
Red Blood Cells, Leukocytes Reduced
FDA recall event 91256 · Class III · Central California Blood Center
Key facts
| Event ID | 91256 |
|---|---|
| Recall numbers | B-0067-2023 |
| Recalling firm | Central California Blood Center |
| Product type | Biologics |
| Products | Red Blood Cells, Leukocytes Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Red Blood Cell product, collected from an unsuitable donor due to a donor screening deviation, was distributed. |
| Initiation date | Jul 10, 2022 |
| Report date | Dec 21, 2022 |
| Termination date | Dec 9, 2022 |
| City | Fresno |
| State | CA |
| Country | United States |
| FEI number | 2970324 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: